Mira - Minocycline in Rheumatoid Arthritis

Trentham, David

Abstract

Funding Agency

• Agency: National Institute of Health (NIH)
• Institute: National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)
• Type: Research and Development Contracts (N01)
• Project #: N01AR012205-005
• Application #: 2298285
• Project Start: 1991-05-15
• Project End: 1994-04-14
• Budget Start: 1993-08-02
• Budget End: 1994-04-14
• Fiscal Year: 1993

Institution

• Name: Beth Israel Deaconess Medical Center
• DUNS #: 076593722
• City: Boston
• State: MA
• Country: United States
• Zip Code: 02215

Publications

Tilley, B C; Pillemer, S R; Heyse, S P et al. (1999) Global statistical tests for comparing multiple outcomes in rheumatoid arthritis trials. MIRA Trial Group. Arthritis Rheum 42:1879-88

Bluhm, G B; Sharp, J T; Tilley, B C et al. (1997) Radiographic results from the Minocycline in Rheumatoid Arthritis (MIRA) Trial. J Rheumatol 24:1295-302

Tuttleman, M; Pillemer, S R; Tilley, B C et al. (1997) A cross sectional assessment of health status instruments in patients with rheumatoid arthritis participating in a clinical trial. Minocycline in Rheumatoid Arthritis Trial Group. J Rheumatol 24:1910-5

Pillemer, S R; Fowler, S E; Tilley, B C et al. (1997) Meaningful improvement criteria sets in a rheumatoid arthritis clinical trial. MIRA Trial Group. Minocycline in Rheumatoid Arthritis. Arthritis Rheum 40:419-25

Reveille, J D; Alarcon, G S; Fowler, S E et al. (1996) HLA-DRB1 genes and disease severity in rheumatoid arthritis. The MIRA Trial Group. Minocycline in Rheumatoid Arthritis. Arthritis Rheum 39:1802-7

Tilley, B C; Alarcon, G S; Heyse, S P et al. (1995) Minocycline in rheumatoid arthritis. A 48-week, double-blind, placebo-controlled trial. MIRA Trial Group. Ann Intern Med 122:81-9